National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Hyaneb® is particularly indicated in patients with cystic fibrosis and in patients with bronchiectasis.  Hyaneb® is classified as a medical device and carries a CE mark.

 Rapid Review

Commenced Completed Outcome
10/02/2014 19/03/2014 Full Pharmacoeconomic Evaluation not recommended